Terbutaline
Active ingredient · 2 therapeutic classes
Sold as BRICANYL TURBOHALER · BRICANYL 500 MICROGRAMS…
- Drug class
- Selective Beta-2-Adrenoreceptor Agonists
- Availability
- Prescription only
- Routes
- Oral, Subcutaneous
- Markets covered
- 2
- Products on record
- 27
Overview
Plain-language summary, compiled from the cited regulatory records
Terbutaline is a medication classified as a selective beta-2-adrenoreceptor agonist [1]. This drug class is used to treat conditions affecting the airways [1].
Terbutaline sulfate is approved for preventing and reversing bronchospasm in individuals aged 12 years and older who have asthma. It is also indicated for reversible bronchospasm associated with bronchitis and emphysema [1].
This active ingredient is available under various brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 25 | May 22, 2026 |
| US United States | FDA | 2 | April 1, 2022 |
GBUnited Kingdom· MHRA
25 products
Uses
Terbutaline is a selective β2-adrenergic agonist recommended for the relief and prevention of bronchospasm in bronchial asthma and other bronchopulmonary disorders in which bronchospasm or reversible airways obstruction is a complicating factor.
How to take
USUnited States· FDA
2 products
Uses
INDICATIONS AND USAGE
Terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
How to take
Drug interactions
Known interactions involving Terbutaline. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 366. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL179010117 · revised February 20, 2026
- [2]FDA DailyMed · 0a95bc4f-34d3-4b… · revised April 1, 2022 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.